Stryker Sees FY24 EPS $11.90-$12.10 Vs $11.95 Est., Anticipates A Moderately Unfavorable Impact On FY Net Sales And Now Expect Adj Net EPS Will Be Negatively Impacted In The Range Of $0.10-$0.15
Portfolio Pulse from Benzinga Newsdesk
Stryker has updated its FY24 EPS guidance to $11.90-$12.10, slightly below the $11.95 estimate. The company anticipates a moderately unfavorable impact on net sales due to foreign exchange rates, affecting adjusted net EPS by $0.10-$0.15. Despite this, Stryker expects organic net sales growth of 9.0%-10.0% with a favorable pricing impact of 0.5%.
July 30, 2024 | 8:12 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Stryker has revised its FY24 EPS guidance to $11.90-$12.10, slightly below the $11.95 estimate. The company expects a moderately unfavorable impact on net sales due to foreign exchange rates, affecting adjusted net EPS by $0.10-$0.15. However, organic net sales growth is projected to be 9.0%-10.0% with a favorable pricing impact of 0.5%.
The updated EPS guidance is slightly below estimates, which could be seen as a negative. However, the strong organic net sales growth projection and favorable pricing impact may offset some of the negative sentiment. The moderately unfavorable impact from foreign exchange rates is a concern but not critical.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100